FRSH:NASDAQFreshworks Inc. Analysis
Data as of 2026-06-17 - not real-time
$9.50
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Freshworks (FRSH) trades around $9.5, well below its DCF‑derived fair value of $27.6, implying roughly a 24% upside. The stock sits just above its 20‑day SMA ($9.42) and 50‑day SMA ($8.86), while the RSI is neutral at 55 and the MACD histogram is slightly negative, suggesting a modest short‑term bias but no strong momentum. Technical indicators point to a neutral trend with a solid support at $8.84 and resistance near $10.69, and volume is on an increasing trajectory, adding liquidity confidence. Fundamentally, FRSH delivers a high gross margin (~85%) and a healthy revenue growth rate of 16.5%, yet operating margin remains negative, though profit margin is positive at 20%. The balance sheet is strong, with $780 M cash against $38 M debt, and free cash flow exceeds $260 M, supporting the undervalued narrative. Recent material news includes a Zacks Rank 1 Strong Buy upgrade and the launch of an AI Agent Studio for Freshservice, both of which could catalyze near‑term demand, while a announced 500‑person reduction introduces a one‑time $8 M restructuring charge.
The valuation metrics—PE of 15.6 versus an industry average of 37, and a price‑to‑book of 2.6—underscore a fairly priced but still discounted position. However, the stock’s 30‑day volatility exceeds 50% and beta under 1 indicate heightened price swings typical for the software‑application sector. Given the mix of strong cash generation, growth prospects, and elevated risk, a nuanced stance across horizons is warranted.
The valuation metrics—PE of 15.6 versus an industry average of 37, and a price‑to‑book of 2.6—underscore a fairly priced but still discounted position. However, the stock’s 30‑day volatility exceeds 50% and beta under 1 indicate heightened price swings typical for the software‑application sector. Given the mix of strong cash generation, growth prospects, and elevated risk, a nuanced stance across horizons is warranted.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Zacks Rank 1 Strong Buy upgrade
- Price above short‑term moving averages
- Support level near $8.84 providing downside cushion
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Undervalued relative to DCF and industry PE
- Revenue growth of 16.5% with high gross margins
- Robust cash position and positive free cash flow
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Operating margin remains negative despite profit margin
- Restructuring charge and workforce reduction
- Long‑term AI product rollout and competitive SaaS landscape
Key Metrics & Analysis
Financial Health
Revenue Growth16.50%
Profit Margin20.69%
P/E Ratio15.6
ROE17.32%
ROA0.62%
Debt/Equity3.81
P/B Ratio2.6
Op. Cash Flow$246.8M
Free Cash Flow$263.7M
Industry P/E37.2
Technical Analysis
TrendNeutral
RSI55.0
Support$8.84
Resistance$10.69
MA 20$9.42
MA 50$8.86
MA 200$10.34
MACDBearish
VolumeIncreasing
Fear & Greed Index92.23
Valuation
Fair Value$27.60
Target Price$11.75
Upside/Downside23.68%
GradeUndervalued
TypeBlend
Risk Assessment
Beta0.80
Volatility52.59%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.